Global Desmoid Tumors Pipeline Insight Report 2023: Promising Therapies to Transform Treatment Landscape
August 15, 2023 05:13 ET
|
Research and Markets
Dublin, Aug. 15, 2023 (GLOBE NEWSWIRE) -- The "Desmoid Tumors - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering. This comprehensive report provides...
20th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production: A Study of Biotherapeutic Developers and Contract Manufacturing Organizations
August 11, 2023 09:23 ET
|
Research and Markets
Dublin, Aug. 11, 2023 (GLOBE NEWSWIRE) -- The "20th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report has been added to ResearchAndMarkets.com's offering. ...
Global Biopharmaceuticals Market Outlook Report 2023-2027: Monoclonal Antibodies Dominate the Market, Driven by Exponential Research and Applications within Oncology
August 11, 2023 04:13 ET
|
Research and Markets
Dublin, Aug. 11, 2023 (GLOBE NEWSWIRE) -- The "Global Biopharmaceuticals Market Outlook to 2027" report has been added to ResearchAndMarkets.com's offering.The global biopharmaceuticals market has...
FibroGen Reports Second Quarter 2023 Financial Results
August 07, 2023 16:01 ET
|
FibroGen, Inc.
Topline data from three late-stage pamrevlumab trials expected through 1H 2024, including the Pancreatic Cancer Action Network (PanCAN) Precision PromiseSM Phase 2/3 study in metastatic pancreatic...
Natural Killer Cells Therapeutics Market Analysis and Industry Forecast to 2027: Advancements in Manufacturing Processes, Cell Engineering Techniques and Development of Combination Therapies
August 07, 2023 06:03 ET
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Natural Killer Cells Therapeutics Market by Therapeutics, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2027" report...
Pasithea Therapeutics publishes study in Proceedings of the National Academy of Sciences (PNAS) that shows an increase in α5 integrin expression in ALS human and mouse brain tissue, and further demonstrates targeting α5 integrin results in improved survival and motor function
August 01, 2023 07:59 ET
|
Pasithea
-- PAS-003 is a monoclonal antibody targeting α5/β1 integrin for the treatment of amyotrophic lateral sclerosis (“ALS”) -- -- Lead α5/β1 integrin drug candidate to be selected in H2 2023 -- ...
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
July 31, 2023 16:05 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development...
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating VIR-2482 for the Prevention of Seasonal Influenza A Illness
July 20, 2023 08:00 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, July 20, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Phase 2 PENINSULA (PrevEntioN of IllNesS DUe to InfLuenza A) trial evaluating VIR-2482...
Global Biologics Contract Development Market to 2030: Increasing Outsourcing of R&D Activities Drives Growth
July 11, 2023 06:03 ET
|
Research and Markets
Dublin, July 11, 2023 (GLOBE NEWSWIRE) -- The "Biologics Contract Development Market 2023-2030" report has been added to ResearchAndMarkets.com's offering.The global biologics contract development...
Global Bispecific Antibodies Market to 2035: Players Include Akeso Biopharma, Amgen, Astrazeneca, Genmab and Immunocore
July 07, 2023 07:18 ET
|
Research and Markets
Dublin, July 07, 2023 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies Market 2023-2035" report has been added to ResearchAndMarkets.com's offering. This report features an extensive study of the...